Catalysts target pharmaceutical applications.October 8, 2008 -
NanoSelect LF 100 and NanoSelect LF 200 for hydrogenation are intended for use in fine chemical and pharmaceutical applications. Lead-free catalysts are characterized by supported well-defined, unimodal nano-sized palladium clusters and are considered environmentally friendly.
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Original Press release
BASF Catalysts LLC
554 Engelhard Dr.
Seneca, SC, 29678
USA
BASF Catalysts Introduces New Pharma Solutions at CPhI Worldwide
Higher efficiency and cost savings with BASF's new NanoSelect(TM) catalysts for hydrogenation reactions in pharma applications.
September 30, 2008
Frankfurt, DE -
BASF Catalysts, the global leader in catalysis, will introduce the first two catalysts from its new NanoSelect(TM) platform technology, NanoSelect LF 100 and NanoSelect LF 200, for use in fine chemical and pharmaceutical applications at the CPhl Worldwide which starts today.
The two catalysts NanoSelect LF 100 and NanoSelect LF 200 were specifically designed to meet the market requirements of providing a Lead-free replacement for Lindlar catalysts, which have long been used in hydrogenation processes. NanoSelect LF 100 and LF 200 are characterized by supported well-defined, unimodal nano-sized palladium clusters and show similar activity and selectivity as Lindlar catalysts in selective hydrogenation reactions. "BASF NanoSelect LF 100 and LF 200 catalysts are an environmentally-friendly alternative for Lindlar catalysts," says Dr. Hans Donkervoort, Global Product Technology Manager Specialty and Fine Chemicals Catalysts at BASF's Catalyst Division. "They additionally offer significant cost savings by having a markedly lower Precious Metal content."
The Catalysts Division is among a number of BASF businesses presenting their extensive expertise for supporting pharmaceutical industry customers at "CPhI Worldwide," the "Convention on Pharmaceutical Ingredients and Intermediates" that will take place in Frankfurt, Germany, from September 30 through October 2, 2008.
BASF's booth 30B04, in Hall 3.0, will bear the motto "Pharma Solutions from BASF." In addition to catalysts, BASF also presents pharma ingredients and custom synthesis services for better drugs, high-end intermediates for the pharmaceutical industry as well as innovative inorganic specialties.
BASF continually develops new intelligent solutions based on the latest catalyst technologies for its customers. The company delivers these "Enabling Technologies" to the fine chemical, pharmaceutical and agrochemical markets to make its customers more successful in their dynamically changing environments. The portfolio of enabling technologies, including precious metal and base metal hetero- and homogeneous catalysts and metal scavenging materials, is continuously strengthened by focused R&D and licensing of new technologies.
BASF's Catalysts division is the world's leading supplier of environmental and process catalysts. The group offers exceptional expertise in the development of technologies that protect the air we breathe, produce the fuels that power our world and ensure efficient production of a wide variety of chemicals, plastics, adsorbents and other products. For more information, please go to www.catalysts.basf.com.
About BASF
BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from oil and gas to chemicals, plastics, performance products, agricultural products and fine chemicals. As a reliable partner BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges such as climate protection, energy efficiency, nutrition and mobility. BASF has more than 95,000 employees and posted sales of almost 58 billion in 2007.BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at www.basf.com
|
|
|
|
|
|
|
| 
